Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00305175 · ClinicalTrials.gov registry record
Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease
A clinical trial, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 260
- Enrollment target
NCT00305175 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 260 participants.
The verdict
NCT00305175 has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 260 participants
- Enrollment target
Study Summary
The primary objectives of this prospective, observational study are (1) to describe the long-term cellular, molecular, and clinical effects of hydroxyurea therapy in sickle cell disease, and (2) to perform hydroxyurea pharmacokinetics studies. This study will follow sickle cell patients being treated with hydroxyurea for a long period of time to evaluate the long-term cellular and molecular effects of the drug on the patients' body. This study will consist of two patient groups. One group will be made up of patients who have received hydroxyurea therapy before entering the study. The second group will be made up of patients who have not received hydroxyurea before study entry.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2006-03-03 |
| Est. Completion | 2015-04-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00305175
The ClinicalTrials.gov registry entry for NCT00305175 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00305175 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00305175 about?
NCT00305175 is a clinical study titled "Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease". The primary objectives of this prospective, observational study are (1) to describe the long-term cellular, molecular, and clinical effects of hydroxyurea therapy in sickle cell disease, and (2) to perform hydroxyurea pharmacokinetics studies. This study will follow sickle cell patients being treat...
What is the current status of trial NCT00305175?
This trial is currently completed. The enrollment target is 260 participants. The study started on 2006-03-03. Estimated completion is 2015-04-23.
Who is sponsoring clinical trial NCT00305175?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.